LENZ Therapeutics, Inc.
LENZ
$38.99
-$0.69-1.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.91M | -14.62M | -12.65M | -10.22M | -10.25M |
| Total Depreciation and Amortization | 19.00K | 36.00K | 25.00K | 10.00K | 18.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.96M | 1.50M | 222.00K | 832.00K | 638.00K |
| Change in Net Operating Assets | 1.43M | -2.97M | 3.33M | -1.21M | -6.20M |
| Cash from Operations | -11.51M | -16.05M | -9.08M | -10.58M | -15.80M |
| Capital Expenditure | -240.00K | -110.00K | -149.00K | -186.00K | -133.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -174.00K | 19.00M | -11.71M | -62.04M | -98.26M |
| Cash from Investing | -414.00K | 18.89M | -11.86M | -62.23M | -98.39M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 26.49M | 44.00K | 53.00K | 29.83M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -150.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -13.00K | -1.99M |
| Cash from Financing | 26.49M | 44.00K | 53.00K | 29.82M | -2.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.57M | 2.88M | -20.89M | -42.99M | -116.32M |